Tsao AS and his colleague show that PDGFR-b has a higher expression and an increase of gene copy number in PSC compared with other NSCLC, which suggests that perhaps PDGFR-b would become a new therapeutic target[20]. This evidence concerns the gene PDGFRB and non-small cell lung carcinoma.